EUVIMEDEUVIMED entdecken
Metaanalyse

Causal relationship between folic acid and prostate cancer risk: Insights from Mendelian randomization analysis

Xiaoxiao Guo iD, Fengbo Zhang, Gangyue Hao

International Journal of Urology · 2024

DOI: 10.1111/iju.15565 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Urology, 2024. Verfasst von Xiaoxiao Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Dietary Supplements, Folic Acid, Genome-Wide Association Study, Mendelian Randomization Analysis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Projects of Beijing Municipal Education Commission, Natural Science Foundation of Capital Medical University, Friendship Hospital Seed Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Folic acid is a commonly used dietary supplement of trace element, but it may increase the risk of prostate cancer (PCa). The aim of this study was to investigate the causal relationship between PCa and folic acid supplementation, as well as dietary folate equivalents, using Mendelian randomization (MR) analysis.

Methods

The Genome‐Wide Association Study (GWAS) data of folic acid supplementation and dietary folate equivalents were selected from UK Biobank. Meta‐analysis of GWASs of PCa was obtained from PCa Association Group to Investigate Cancer‐Associated Alterations in the Genome consortium. MR analysis was performed with inverse variance weighted (IVW) method, MR‐Egger regression, simple mode, weighted median, and weighted mode analysis. Heterogeneity and horizontal pleiotropy tests and reverse MR analysis were conducted to assess the robustness and reliability of the causal inference.

Results

Six single nucleotide polymorphisms (SNPs) associated with folic acid supplementation and five SNPs associated with dietary folate equivalents were identified as instrumental variables. Genetically predicted folic acid supplementation was associated with an increased risk of PCa (OR 1.200, p < 0.001, by IVW method), and there was no evidence of heterogeneity, horizontal pleiotropy, or significant reverse causality (all p > 0.05). In contrast, dietary folate equivalents showed no significant correlation with PCa ( p > 0.05 for all five MR methods).

Conclusion

This study demonstrated an association between increased risk of PCa and folic acid supplementation, but not with dietary folate equivalents. These findings have implications for public health interventions and personalized preventive strategies for PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsFolic AcidGenome-Wide Association StudyMendelian Randomization AnalysisPolymorphism, Single NucleotideProstatic NeoplasmsHumansMaleRisk Factors

Stichwörter der Autor:innen

Mendelian randomizationdietary folate equivalentsfolic acid supplementationgenome‐wide association studyprostate cancer

Substanzen

Folic Acid

Autor:innen und Institutionen

  • Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Institute of Urology, Beijing Municipal Health Commission, Beijing, China.

ORCID-Profile: Xiaoxiao Guo

Förderung

  • Projects of Beijing Municipal Education Commission
  • Natural Science Foundation of Capital Medical University
  • Friendship Hospital Seed Program

Zitieren

APA

Guo, X., Zhang, F., & Hao, G. (2024). Causal relationship between folic acid and prostate cancer risk: Insights from Mendelian randomization analysis. International Journal of Urology. https://doi.org/10.1111/iju.15565

Vancouver

Guo X, Zhang F, Hao G. Causal relationship between folic acid and prostate cancer risk: Insights from Mendelian randomization analysis. International Journal of Urology. 2024. doi:10.1111/iju.15565

BibTeX
@article{Guo2024,
  author = {Guo, Xiaoxiao and Zhang, Fengbo and Hao, Gangyue},
  title = {Causal relationship between folic acid and prostate cancer risk: Insights from Mendelian randomization analysis},
  journal = {International Journal of Urology},
  year = {2024},
  doi = {10.1111/iju.15565}
}
Kostenlos starten →